Статті в журналах з теми "Gcb-Dlbcl"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Gcb-Dlbcl".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Pukiat, Sulada, Nuttapong Ngamphaiboon, Pooja Advani, Julio Chavez, George Deeb, Anjana Elefante, and Francisco J. Hernandez-Ilizaliturri. "BCL-2 Expression at the Time of Diagnosis Affects the Clinical Outcome of Patients with Germinal Center and Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Chemo-Immunotherpy." Blood 116, no. 21 (November 19, 2010): 3130. http://dx.doi.org/10.1182/blood.v116.21.3130.3130.
Tarius, Jenifer Marsela, Hermawan Istiadi, Ika Pawitra Miranti, and Intan Rahmania Eka Dini. "THE CORRELATION BETWEEN CELL OF ORIGIN SUBTYPE WITH OVERALL SURVIVAL OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS IN KARIADI GENERAL HOSPITAL SEMARANG." DIPONEGORO MEDICAL JOURNAL (JURNAL KEDOKTERAN DIPONEGORO) 9, no. 3 (May 12, 2020): 252–58. http://dx.doi.org/10.14710/dmj.v9i3.27504.
Gandhi, Shipra, Vishala T. Neppalli, George Deeb, Myron S. Czuczman, and Francisco J. Hernandez-Ilizaliturri. "Distinct CD30 Expression Patterns In Germinal Center B-Cell (GCB) and Non-GCB Diffuse Large B-Cell Lymphoma (DLBCL)." Blood 122, no. 21 (November 15, 2013): 5064. http://dx.doi.org/10.1182/blood.v122.21.5064.5064.
Hayama, Miyuki, Masataka Okamoto, Yuki Hagiwara, Ken Tanae, Mika Kohri, Naoki Takahashi, Tadashi Yoshino, Koichi Ohshima, and Nozomi Niitsu. "Clinical Significance of Immunohistochemical Markers of Diffuse Large B-Cell Lymphoma In the Rituximab Era." Blood 116, no. 21 (November 19, 2010): 1800. http://dx.doi.org/10.1182/blood.v116.21.1800.1800.
Kharchenko, Yevgeniya, Tatyana Semiglazova, Anna Artemeva, Galina Kireeva, I. Polyatskin, Ilya Zyuzgin, Larisa Filatova, Yuliya Chudinovskikh, Margarita Motalkina, and Yuliya Oleynik. "PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL AND MOLECULAR GENETIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA." Problems in oncology 66, no. 1 (January 1, 2020): 79–89. http://dx.doi.org/10.37469/0507-3758-2020-66-1-79-89.
Adhi Pangarsa, Eko, Desta Nur Ewika Ardini, Daniel Rizky, Kevin Tandarto, Hermawan Istiadi, Dik Puspasari, Budi Setiawan та ін. "The association of Hypoxia-Inducible Factor-2α (HIF-2α) overexpression score with Germinal Center B-Cell Like (GCB) and Non-Germinal Center B-Cell Like (Non-GCB) subtypes of Diffuse Large B-cell Lymphoma (DLBCL)". Bali Medical Journal 12, № 3 (22 серпня 2023): 2456–62. http://dx.doi.org/10.15562/bmj.v12i3.4521.
Mishima, Yuko, Masahiro Yokoyama, Noriko Nishimura, Kyoko Ueda, Tadahiro Gunji, Hideaki Nitta, Yoshiharu Kusano, et al. "R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL." Blood 126, no. 23 (December 3, 2015): 1507. http://dx.doi.org/10.1182/blood.v126.23.1507.1507.
Chavez, Julio, Mark Walsh, Francisco J. Hernandez-Ilizaliturri, Anjana Elefante, and Myron S. Czuczman. "Classification of Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) According to the Han's Criteria Defines Two Groups of Patients with Different Clinical Outcomes Following Systemic Rituximab-Multi Agent Anthracycline-Based Therapy." Blood 114, no. 22 (November 20, 2009): 623. http://dx.doi.org/10.1182/blood.v114.22.623.623.
Van Meerten, Tom, Renee Bouwstra, Yuan He, de Boer Janneke, Hilde Kooistra, Rudolf Fehrmann, Emanuele Ammatuna, Gerwin Huls, and Edwin Bremer. "CD47 Expression Defines the Efficacy of Rituximab in Non-Germinal Center B-Cell (non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)." Blood 132, Supplement 1 (November 29, 2018): 2852. http://dx.doi.org/10.1182/blood-2018-99-114561.
Niitsu, Nozomi, Naoki Takahashi, Tadashi Yoshino, Masataka Okamoto, and Shigeo Nakamura. "Prognostic Significance of EBV Association in Diffuse Large B-Cell Lymphoma in the Rituximab Era." Blood 126, no. 23 (December 3, 2015): 3911. http://dx.doi.org/10.1182/blood.v126.23.3911.3911.
Alam, SM Mahbubul, and Ahmed Khaled. "Immunophenotypic characteristics of Diffuse Large Bcell Lymphoma." Bioresearch Communications 8, no. 1 (December 26, 2021): 1049–52. http://dx.doi.org/10.3329/brc.v8i1.57043.
Nooruddin, Zohra, Zenggang Pan, Lilyana Gross, Weitzenkamp David, Bradley M. Haverkos, Daniel A. Pollyea, Jonathan A. Gutman, et al. "Post-Transplant Diffuse Large B Cell Lymphoma with Non Germinal Center B-Cell Subtype Frequently Lacks Programmed Cell Death Ligand (PD-L1) Overexpression Which May Influence Overall Outcomes." Blood 128, no. 22 (December 2, 2016): 3054. http://dx.doi.org/10.1182/blood.v128.22.3054.3054.
Slimani, Yasmine, Fouzia Hali, and Fatima-Zohra El Fatoiki. "Triple-negative diffuse large B-cell lymphoma: A distinct entity." Our Dermatology Online 12, no. 4 (October 19, 2021): 427–29. http://dx.doi.org/10.7241/ourd.20214.17.
Lossos, Izidore S., XiaoQing Lu, Feiying Ding, Manuel Rosado, Ash A. Alizadeh, and Hovav Nechushtan. "Distinct IL-4 Intracellular Signaling in Germinal Center B-Cell like and Activated B-Cell like Diffuse Large B-Cell Lymphoma: Novel Opportunities for Therapeutic Interventions." Blood 104, no. 11 (November 16, 2004): 244. http://dx.doi.org/10.1182/blood.v104.11.244.244.
Costa, Luciano J., Andrew L. Feldman, Ivana N. Micallef, David J. Inward, Patrick B. Johnston, Luis F. Porrata, Mark R. Litzow, and Stephen M. Ansell. "Germinal Center B Cell and Non-Germinal Center B Cell-Like DLBCL Have Similar Clinical Features at the Time of Progression and Comparable Outcome Following Autologous HSC Transplantation." Blood 110, no. 11 (November 16, 2007): 1901. http://dx.doi.org/10.1182/blood.v110.11.1901.1901.
Julianty, Patricia Fransisca, Maria Francisca Ham, Kusmardi Kusmardi, and Agnes Stephanie Harahap. "CD30 Expression in Germinal Center B-cell-like and non-Germinal Center B-cell-like Subtypes of Diffuse Large B-cell Lymphoma." Open Access Macedonian Journal of Medical Sciences 8, B (April 17, 2020): 375–80. http://dx.doi.org/10.3889/oamjms.2020.4645.
Lenz, Georg, George Wright, Sandeep Dave, Alexander Kohlmann, Wenming Xiao, John Powell, Hong Zhao, et al. "Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy." Blood 110, no. 11 (November 16, 2007): 348. http://dx.doi.org/10.1182/blood.v110.11.348.348.
Nechushtan, Hovav, Joseph D. Rosenblatt, and Izidore S. Lossos. "IL-4 Affects Proliferation, Chemosensitivity-and Rituximab Sensitivity of Germinal Center B-Cell like (GCB) and Activated B-Cell like (ABC) Diffuse Large B-Cell Lymphoma Differently." Blood 104, no. 11 (November 16, 2004): 242. http://dx.doi.org/10.1182/blood.v104.11.242.242.
Locatelli, Silvia L., Roberto Papait, Giuseppa Careddu, Ada Koschorke, Giuliano G. Stirparo, Monica Balzarotti, Luca Castagna, Armando Santoro, and Carmelo Carlo-Stella. "Upregulation of Cereblon Expression By the DNA Methyltransferase Inhibitor Azacytidine Strongly Enhances Lenalidomide Cytotoxicity in Germinal Center B-Cell-like (GCB) and Activated B-Cell-like (ABC) Diffuse Large B-Cell Lymphoma (DLBCL)." Blood 124, no. 21 (December 6, 2014): 2253. http://dx.doi.org/10.1182/blood.v124.21.2253.2253.
Kleinstern, Geffen, Dennis P. Robinson, Lisa M. Rimsza, Melissa C. Larson, Rebecca L. King, Grzegorz S. Nowakowski, Carrie A. Thompson, et al. "Abstract 741: Evaluation of etiologic heterogeneity for risk of diffuse large B-cell lymphoma (DLBCL) subtype defined by cell-of-origin." Cancer Research 82, no. 12_Supplement (June 15, 2022): 741. http://dx.doi.org/10.1158/1538-7445.am2022-741.
Fu, Kai, Dennis D. Weisenburger, William W. L. Choi, Kyle D. Perry, Lynette M. Smith, Xinlan Shi, Christine P. Hans, et al. "Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of Diffuse Large B-Cell Lymphoma." Journal of Clinical Oncology 26, no. 28 (October 1, 2008): 4587–94. http://dx.doi.org/10.1200/jco.2007.15.9277.
Cao, Yabing, Ying Huang, Sheng Ye, and Tongyu Lin. "Prognostic impact of immunohistochemically defined germinal center B-cell and nongerminal center B-cell subtypes of diffuse large B-cell lymphoma in rituximab era." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e18517-e18517. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e18517.
Huang, Ying, Sheng Ye, Yabing Cao, Zhiming Li, Jiajia Huang, He Huang, Muyan Cai, Rongzhen Luo, and Tongyu Lin. "Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients." Scientific World Journal 2012 (2012): 1–7. http://dx.doi.org/10.1100/2012/897178.
Dunleavy, Kieron, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Dave, George Wright, Nicole Grant, Margaret Shovlin, et al. "Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma." Blood 113, no. 24 (June 11, 2009): 6069–76. http://dx.doi.org/10.1182/blood-2009-01-199679.
Wenzl, Kerstin, Bryce Manso, Yan W. Asmann, Matthew J. Maurer, Michelle Manske, Zhi-Zhang Yang, Susan L. Slager, et al. "Whole-Exome Analysis Reveals Novel Somatic Genomic Alterations Associated with Cell of Origin in Diffuse Large B-Cell Lymphoma." Blood 128, no. 22 (December 2, 2016): 2935. http://dx.doi.org/10.1182/blood.v128.22.2935.2935.
De Paepe, Pascale, Ruth Achten, Gregor Verhoef, Iwona Wlodarska, Michel Stul, Vera Vanhentenrijk, Marleen Praet, and Chris De Wolf-Peeters. "Large Cleaved and Immunoblastic Lymphoma May Represent Two Distinct Clinicopathologic Entities Within the Group of Diffuse Large B-Cell Lymphomas." Journal of Clinical Oncology 23, no. 28 (October 1, 2005): 7060–68. http://dx.doi.org/10.1200/jco.2005.15.503.
Dekker, Joseph D., Daechan Park, Arthur L. Shaffer, Holger Kohlhammer, Wei Deng, Bum-Kyu Lee, Gregory C. Ippolito, et al. "Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1." Proceedings of the National Academy of Sciences 113, no. 5 (January 19, 2016): E577—E586. http://dx.doi.org/10.1073/pnas.1524677113.
Waller, Rosalie Griffin, Dennis P. Robinson, Anne J. Novak, Lisa M. Rimsza, Kerstin Wenzl, Rebecca L. King, Andrew L. Feldman, et al. "Abstract 1181: Etiologic heterogeneity of genetic risk for DLBCL cell-of origin molecular subtypes." Cancer Research 83, no. 7_Supplement (April 4, 2023): 1181. http://dx.doi.org/10.1158/1538-7445.am2023-1181.
Kim, Yu Ri, Soo-Jeong Kim, June-Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Deok-Hwan Yang, et al. "Upfront Autologous Stem Cell Transplantation Overcome the poor Prognosis of Non-Germinal Center Subtype of diffuse Large B-Cell Lymphoma in Patients with Advanced Stage and Elevated Serum Lactate Dehydrogenase." Blood 124, no. 21 (December 6, 2014): 3998. http://dx.doi.org/10.1182/blood.v124.21.3998.3998.
Soo, Joanne, David Matthew Kurtz, Florian Scherer, Alexander F. M. Craig, Michael C. Jin, Jason R. Westin, Davide Rossi, et al. "Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 7538. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.7538.
Xu-Monette, Zijun Y., Ling Li, John C. Byrd, Kausar J. Jabbar, Ganiraju C. Manyam, Charlotte Maria de Winde, Michiel van den Brand, et al. "Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma." Blood 128, no. 26 (December 29, 2016): 3083–100. http://dx.doi.org/10.1182/blood-2016-05-715094.
Foureau, David, Lawrence J. Druhan, Nury M. Steuerwald, Sarah A. Baxter, Omotayo O. Fasan, Belinda R. Avalos, and Nilanjan Ghosh. "Cytokine Profiling of ABC-Subtype and GCB-Subtype Diffuse Large B Cell Lymphoma: Systemic Nfkb Activation and Impact on Myeloid-Derived Suppressor Cells Distribution." Blood 126, no. 23 (December 3, 2015): 2666. http://dx.doi.org/10.1182/blood.v126.23.2666.2666.
Havranek, Ondrej, Jingda Xu, Stefan Koehrer, Zhiqiang Wang, Justin M. Comer, Lisa Becker, Allen F. Yi, et al. "Molecular Aspects of Tonic B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma Provide Biomarkers and Targets for Specific Inhibition." Blood 128, no. 22 (December 2, 2016): 779. http://dx.doi.org/10.1182/blood.v128.22.779.779.
Takizawa, Jun, Sadao Aoki, Akihito Momoi, Toshiki Kitajima, Masutaka Higashimura, Naoya Nakamura, and Yoshifusa Aizawa. "BCL6 Rearrangement Detected by FISH Analysis Is a Poor Prognostic Factor in the “Non-Germinal Center Phenotype” of Diffuse Large B-Cell Lymphoma." Blood 108, no. 11 (November 16, 2006): 4620. http://dx.doi.org/10.1182/blood.v108.11.4620.4620.
Gupta, Mamta, Guangzhen Hu, Steven Offer, Matthew J. Maurer, Linda Wellik, Jing Jing Han, Ahmet Dogan, Robert B. Diasio, and Thomas E. Witzig. "Expression but Not Promoter Hypermethylation of the Tyrosine Phosphatase PTPN6 Is Associated with Activated STAT3 and Inferior Prognosis in Diffuse Large B Cell Lymphoma Molecular Subtypes." Blood 120, no. 21 (November 16, 2012): 2655. http://dx.doi.org/10.1182/blood.v120.21.2655.2655.
Zhao, Fengyi, Lei Zhang, Yan Qin, Ming-Zhe Han, Xiaohong Han, Shiyu Jiang, and Yuankai Shi. "Characterization of Methylation Patterns in Diffuse Large B Cell Lymphoma By Genome-Wide Methylation Analysis." Blood 134, Supplement_1 (November 13, 2019): 1243. http://dx.doi.org/10.1182/blood-2019-131656.
Alcoceba, Miguel, Elena Sebastián, Ana Balanzategui, Luis Marín, Santiago Montes-Moreno, Teresa Flores, Noemí Puig, et al. "Preferential Acquision of N-Glycosylation Sites in the VDJ Region in Germinal Center B-Cell-Like Difusse Large B-Cell Lymphoma." Blood 120, no. 21 (November 16, 2012): 1589. http://dx.doi.org/10.1182/blood.v120.21.1589.1589.
Nowakowski, Grzegorz S., Betsy LaPlant, William R. Macon, Craig B. Reeder, James M. Foran, Garth D. Nelson, Carrie A. Thompson, et al. "Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study." Journal of Clinical Oncology 33, no. 3 (January 20, 2015): 251–57. http://dx.doi.org/10.1200/jco.2014.55.5714.
Gozgit, Joseph M., Youngchul Song, Scott Wardwell, Sara Nadworny, Yaoyu Ning, and Victor M. Rivera. "Potent Preclinical Activity of Ponatinib in Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma (GCB-DLBCL) Models." Blood 126, no. 23 (December 3, 2015): 4000. http://dx.doi.org/10.1182/blood.v126.23.4000.4000.
Zettl, Andreas, Silvia Bea, George Wright, Itziar Salaverria, Philipp Jehn, German Ott, Wing-Chung Chan, et al. "Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work)." Blood 104, no. 11 (November 16, 2004): 415. http://dx.doi.org/10.1182/blood.v104.11.415.415.
Cao, Y., T. Lin, S. Wang, X. Fu, J. Xiao, J. Yi, H. Lin, and Z. Guan. "A phase II study of R-CHOP in treatment of diffuse large B-cell lymphoma (DLBCL) subgroups." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 17540. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.17540.
Zhao, Peiqi, Huilai Zhang, Kai Fu, Xianhuo Wang, Lanfang Li, Zhengzi Qian, Lihua Qiu, and Shiyong Zhou. "CD5 Expression Correlates with Inferior Survival and Enhances the Negative Effect of p53 Overexpression in Diffuse Large B Cell Lymphoma." Blood 134, Supplement_1 (November 13, 2019): 4117. http://dx.doi.org/10.1182/blood-2019-127666.
Wang, Y. Lynn, Jiao Ma, Wei Xing, Pin Lu, Karen Dresser, Ailin Guo, Anjali Pandey, Pamela B. Conley, Hongbo Yu, and Greg Coffey. "SYK and STAT3 Are Active in Diffuse Large B-Cell Lymphoma: Activity of Cerdulatinib, a Dual SYK/JAK Inhibitor." Blood 124, no. 21 (December 6, 2014): 926. http://dx.doi.org/10.1182/blood.v124.21.926.926.
Feng, Ru, Xiaolei Wei, Meng Xu, Fen Huang, Yongqiang Wei, Tong Zhao, and B. Hilda Ye. "STAT3 Predicts Poor Outcome In Patients With Advanced Diffuse Large B Cell Lymphoma." Blood 122, no. 21 (November 15, 2013): 5069. http://dx.doi.org/10.1182/blood.v122.21.5069.5069.
Qu, Jie, Matthew J. Maurer, James R. Cerhan, Anne J. Novak, Thomas M. Habermann, William R. Macon, Andrew L. Feldman, et al. "Similar Phenotypes Demonstrated upon Initial Diagnosis and at Time of Recurrence in Relapsed DLBCL." Blood 128, no. 22 (December 2, 2016): 5299. http://dx.doi.org/10.1182/blood.v128.22.5299.5299.
Ennishi, Daisuke, Ali Bashashati, Saeed Saberi, Anja Mottok, Barbara Meissner, Merrill Boyle, Susana Ben-Neriah, et al. "Frequent Genetic Alterations of PI3K-AKT Pathway and Their Clinical Significance in Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma." Blood 128, no. 22 (December 2, 2016): 607. http://dx.doi.org/10.1182/blood.v128.22.607.607.
Prakash, Gaurav, Atul Sharma, Vinod Raina, Lalit Kumar, and Mehar C. Sharma. "Outcome in different molecular subtypes of diffuse large B-cell lymphoma: Indian experience." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e18518-e18518. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e18518.
Yunalda, Indah, Krisna Murt, Aida Farida, Ika Kartika, and Erial Bahar. "Density of CD8 in Tumor Microenvironment of Diffuse Large B Cell Lymphoma Subtypes." Majalah Patologi Indonesia 30, no. 2 (May 1, 2021): 227–33. http://dx.doi.org/10.55816/mpi.v30i2.466.
Tatterton, Dylan J., Benjamin Sale, Joel Allen, Maddy L. Newby, Giorgia Chiodin, Patrick J. Duriez, John Butler, et al. "Oligomannose-Type Glycans in the Antigen Binding Site Identify Origin and Prognosis of Diffuse Large B Cell Lymphoma." Blood 142, Supplement 1 (November 28, 2023): 428. http://dx.doi.org/10.1182/blood-2023-188721.
Fu, K., K. D. Perry, L. M. Smith, C. P. Hans, T. C. Greiner, W. C. Chan, D. D. Weisenburger, et al. "Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 8040. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.8040.